DNA damage distribution in the human brain as shown by in situ end labeling; area-specific differences in aging and Alzheimer disease in the absence of apoptotic morphology

Journal of Neuropathology and Experimental Neurology

Volumn 56, Issue 8, 1997, Pages 887-900

  Lucassen, P J ^a,c   Chung, W C J ^a   Kamphorst, W ^b   Swaab, D F ^a  

^a NETHERLANDS INSTITUTE FOR NEUROSCIENCE   (Netherlands)

^b VU UNIVERSITY AMSTERDAM   (Netherlands)

^c LEIDEN UNIVERSITY   (Netherlands)

Author keywords

Alzheimer disease; Apoptosis; DNA damage; Hippocampus; Hypothalamus1 Necrosis; Postmortem delay

Indexed keywords

ADULT; AGED; AGING; ALZHEIMER DISEASE; APOPTOSIS; ARTICLE; AUTOPSY; CLINICAL ARTICLE; CONTROLLED STUDY; DEGENERATIVE DISEASE; DNA DAMAGE; FEMALE; HIPPOCAMPUS; HUMAN; HUMAN TISSUE; HYPOTHALAMUS; MALE; NERVE CELL NECROSIS; NEUROPATHOLOGY; PRIORITY JOURNAL; TEMPORAL CORTEX; TISSUE SPECIFICITY;

EID: 0030806869     PISSN: 00223069     EISSN: None     Source Type: Journal    
DOI: 10.1097/00005072-199708000-00007     Document Type: Article

References (86)

1. Hoogendijk WJ, Pool CW, Troost D, Van Zwieten EJ, Swaab DF. Image analyser-assisted morphometry of the locus coeruleus in Alzheimer's disease, Parkinson's disease and amyotrophic lateral sclerosis. Brain 1995;118:131-43
2. Marcyniuk B, Mann DMA, Yates PO. The topography of cell loss from locus coeruleus in Alzheimer's disease. J Neurol Sci 1986;76: 335-45
3. Mann DMA. The neuropathology of Alzheimer's disease: A review with pathogenic, etiological and therapeutic considerations. Mech Ageing Dev 1985;31:213-55
4. Swaab DF, Grundke-Iqbal I, Iqbal K, Kremer HPH, Ravid R, Van de Nes JAP. τ and ubiquitin in the human hypothalamus in aging and Alzheimer's disease. Brain Res 1992;590:239-49
5. Vereecken ThHLG, Vogels OJM, Nieuwenhuys R. Neuron loss and shrinkage in the amygdala in Alzheimer's disease. Neurobiol Aging 1994;15:45-54
6. West MJ. Regionally specific loss of neurons in the aging human hippocampus. Neurobiol Aging 1993;14:287-93
7. West MJ, Coleman PD, Flood DG, Troncoso JC. Differences in the pattern of hippocampal neuronal loss in normal ageing and Alzheimer's disease. Lancet 1994;344:769-72
8. De Leon MJ, George AE, Stylopoulos LA, Smith G, Miller DC. Early marker for Alzheimer's disease: The atrophic hippocampus. Lancet 1989;ii:672-73
9. De Leon MJ, George AE, Golomb J, et al. Frequency of hippocampal formation atrophy in normal aging and Alzheimer's disease. Neurobiol Aging 1997;18:1-11
10. Jack CR Jr, Petersen RC, O'Brien PC, Tangalos EG. MRI-based hippocampal volumetry in the diagnosis of Alzheimer's disease. Neurology 1992;42:183-88
11. Salehi A, Lucassen PJ, Pool CW, Gonatas NK. Ravid R, Swaab DF. Decreased neuronal activity in the nucleus basalis of Meynert in Alzheimer's disease as suggested by the size of the Golgi apparatus. Neuroscience 1994;59:871-80
12. Scott SA, DeKosky ST Sparks DL, Knox CA, Scheff SW. Amygdala cell loss and atrophy in Alzheimer's disease. Ann Neurol 1992; 32:555-63
13. Swaab DF, Hofman MA, Lucassen PJ, Salehi A, Uylings HBM. Neuronal atrophy, not cell death, is the main hallmark of Alzheimer's disease. Neurobiol Aging 1994;15:369-71
14. Richter C, Park JW, Ames BN. Normal oxidative damage to mitochondrial and nuclear DNA is extensive. Proc Natl Acad Sci USA 1988;85:6465-67
15. Sinet P-M, Ceballos-Picot I. Role of free radicals in Alzheimer's disease and Down's syndrome. In: Pracker L, Prilipko L, Christen Y, eds. Free radicals in the brain. Aging, neurological and mental disorders, Springer-Verlag Berlin New York 1992:91-98
16. Halliwell B. Reactive oxygen species and the central nervous system. In: Packer L, Prilipko L, Christen Y, eds. Free radicals in the brain; aging, neurological and mental disorders, Springer Verlag, Berlin. 1992:21-40
17. Gaubatz JW, Tan BH. Aging affects the levels of DNA damage in postmitotic cells. In: Pierpaoli W, Regelson W, Fabris N, eds. Ann NY Acad Sci 719:97-107
18. Ames BN, Shigenaga MK. Oxidants are a major contributor to aging. In: Franceschi C, Crepaldi G, Cristofalo VJ, Vijg J, eds. Ann NY Acad Sci 1992;663:85-96
19. Riley PA. Free radicals in biology: Oxidative stress and the effects of ionizing radiation. Int J Radiat Biol 1994;65:27-33
20. Floyd RA, Carney JM. Free radical damage to protein and DNA: Mechanisms involved and relevant observations on brain undergoing oxidative stress. Ann Neurol 1992;32:S22-S27
21. Friedlich AL, Butcher LL. Involvement of free oxygen radicals in ß-amyloidosis; An hypothesis. Neurobiol Aging 1994;15:443-55
22. Jones SK, Nee LE, Sweet L, Polinsky RJ, Bartlett JD, Bradley WG, Robison SH. Decreased DNA repair in familial Alzheimer's disease. Mutation Res 1989;219:247-55
23. Robison SH, Bradley WG. Impaired DNA repair replication in Alzheimer's disease cells. In: Hutton JT, Kenney AD, eds. Neurology and neurobiology, vol. 18: Senile dementia of the Alzheimer's type. New York: Alan R. Liss, 1985:205-58
24. Robison SH, Munzer JS, Tandan R, Bradley WG. Alzheimer's disease cells exhibit defective repair of alkylating agent-induced DNA damage. Ann Neurol 1987;21:250-58
25. Mullaart E, Boerrigter METI, Ravid R, Swaab DF, Vijg J. Increased levels of DNA breaks in cerebral cortex of Alzheimer's disease. Neurobiol Aging 1990;11:169-73
26. Mecocci P, MacGarvey U, Kaufman AE, Koontz D, Shoffner JM, Wallace DC, Beal MF. Oxidative damage to mitochondrial DNA shows marked age-dependent increases in human brain. Ann Neurol 1993;34:609-16
27. Mecocci P, MacGarvey U, Beal MF. Oxidative damage to mitochondrial DNA is increased in Alzheimer's disease. Ann Neurol 1994;36:747-51
28. TeKoppele JM, Lucassen PJ, Sakkee AN, et al. 8OHDG levels in brain do not indicate oxidative DNA damage in Alzheimer's disease. Neurobiol Aging 1996;17:819-26
29. Gavrieli Y, Sherman Y, Ben-Sasson SA. Identification of programmed cell death in situ via specific labeling of nuclear DNA fragmentation. J Cell Biol 1992;119:493-501
30. Wijsman JH, Jonker RR, Keijzer R, Van de Velde CJH, Cornelisse CJ, Van Dierendonck JH. A new method to detect apoptosis in paraffin sections: In situ end labeling of fragmented DNA. J Histochem Cytochem 1993;41:7-12
31. Iseki S. DNA strand breaks in rat tissues as detected by in situ nick translation. Exp Cell Res 1986;167:311-26
32. Kressel M, Groscurth P. Distinction of apoptotic and necrotic cell death by in situ end labeling of fragmented DNA. Cell Tissue Res 1994;278:549-56
33. Gold R, Schmied M, Giegerich G, Breitschopf H, Hartung HP, Toyka KV, Lassmann H. Differentiation between cellular apoptosis and necrosis by the combined use of in situ tailing and nick translation techniques. Lab Invest 1994;71:219-25
34. Lucassen PJ, Chung WCJ, Vermeulen JP, Van Lockeren Campagne M, Van Dierendonck J-H, Swaab DF. Microwave-enhanced in situ end-labeling of fragmented DNA; parametric studies in relation to post mortem delay and fixation of rat and human brain. J Histochem Cytochem 1995;43:1163-71
35. Lassmann H, Bancher C, Breitschopf H, Wegiel J, Bobinski M, Jellinger K, Wisniewski HM. Cell death in Alzheimer's disease evaluated by DNA fragmentation in situ. Acta Neuropathol 1995; 89:35-41
36. Migheli A, Cavalla P, Marino S, Schiffer D. A study of apoptosis in normal and pathologic nervous tissue after in situ end labeling of DNA strand breaks. J Neuropathol Exp Neurol 1994;53:606-16
37. Petito CK, Roberts B. Effect of postmortem interval on in situ end-labeling of DNA oligosomes. J Neuropathol Exp Neurol 1995;54: 761-63
38. Anderson AJ, Su JH, Cotman CW. DNA damage and apoptosis in Alzheimer's disease: Colocalization with c-jun immunoreactivity, relationship to brain area, and effect of postmortem delay. J Neurosci 1996;16:1710-19
39. Mann DMA, Yates PO, Marcyniuk B. Some morphometric observations on the cerebral cortex and hippocampus in presenile Alzheimer's disease, senile dementia of Alzheimer's type and Down syndrome in middle age. J Neurol Sci 1985;69:139-59
40. Price JL, Davis PB, Morris JC, White DL. The distribution of tangles, plaques and related immunohistochemical markers in healthy aging and Alzheimer's disease. Neurobiol Aging 1991;12:295-312
41. Swaab DF, Hofman MA, Lucassen PJ, Purba JS, Raadsheer FC, Van de Nes JAP. Functional neuroanatomy and neuropathology of the human hypothalamus. Anat Embryol 1993;187:317-30
42. Fliers E, Swaab DF, Pool CW, Verwer RWH. The vasopressin and oxytocin neurons in the human supraoptic and paraventricular nucleus; changes with aging and in senile dementia. Brain Res 1985;342:45-53
43. Hoogendijk JE, Fliers E, Swaab DF, Verwer RWH. Activation of vasopressin neurons in the human supraoptic and paraventricular nucleus in senescence and senile dementia. J Neurol Sci 1985;69: 291-99
44. Lucassen PJ, Ravid R, Gonatas NK, Swaab DF. Activation of human supraoptic and paraventricular nucleus neurons with aging and in Alzheimer's disease as judged from increasing size of the Golgi apparatus. Brain Res 1993;632:105-13
45. Lucassen PJ, Salehi A, Pool CW, Gonatas NK, Swaab DF. Activation of vasopressin neurons in aging and in Alzheimer's disease. J Neuroendocrinol 1994;6:673-79
46. Etienne P, Robitailli Y, Wood P, Gauthier S, Nair NPV, Quirain R. Nucleus basalis neuronal loss, neuritic and choline acetyltransferase activity in advanced Alzheimer's disease. Neuroscience 1986;19: 1279-91
47. Patil MS, SE Locher, PV Hariharan. Radiation-induced thymine base damage and its excision repair in active and inactive chromatin of HeLa cells. Int J Radiat Biol 1985;48:691-700
48. Peretz B, Zolman JF. Regular activation contributes to differential aging of motor neurons in Aplysia. In: Boer HH, Geraerts WPM, Joosse J, eds. Neurobiology molluscan models. Proceedings of the 2nd symposium on molluscan neurobiology. Amsterdam: North Holland Publishing Company, 1987:330-34
49. Okumoto DS, Bohr VA. DNA repair in the metallothionein gene increases with transcriptional activation. Nucleic Acids Res 1987; 15:10021-30
50. Swaab DF. Brain aging and Alzheimer's disease, "Wear and Tear" versus "Use It Or Lose It." Neurobiol Aging 1991;12:317-24
51. McKahn G, Drachman D, Folstein M, Katzman R, Price D, Stadlan EM. Clinical diagnosis of Alzheimer's disease: Report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's disease. Neurology 1984;34:939-44
52. Van de Nes JAP, Kamphorst W, Ravid R, Swaab DF. The distribution of Alz-50 immunoreactivity in the hypothalamus and adjoining areas of Alzheimer's disease patients. Brain 1993;116:103-15
53. Henderson C. Aminoalkylsilane: An inexpensive, simple preparation for slide adhesion, J Histotechn 1989;12:123-24
54. Kihara S, Shiraishi T, Nakagawa S, Toda K, Tabuchi K. Visualization of DNA double strand breaks in the gerbil hippocampal CA1 following transient ischemia. Neurosci Lett 1994;175:133-36
55. Li Y, Chopp M, Jiang N, Yao F, Zaloga C. Temporal profile of in situ DNA fragmentation after transient middle cerebral artery occlusion in the rat. J Cerebr Blood Flow Metab 1995;15:389-97
56. Lucassen PJ, Williams A, Chung WCJ, Fraser H. Detection of apoptosis in murine scrapie. Neuroscience Lett 1995;198:185-88
57. MacManus JP, Hill IE, Huang ZG, Rasquinha I, Xue D, Buchan AM. DNA damage consistent with apoptosis in transient focal ischaemic neocortex. Neuroreport 1994;5:493-96
58. Van Lookeren Campagne M, Lucassen PJ, Vermeulen JP, Balázs R. NMDA and kainate induce internucleosomal DNA fragmentation and apoptotic cell death in the neonatal rat brain. Eur J Neurosci 1995;7:1627-40
59. Zhang L, Kokkonen G, Roth GS. Identification of neuronal programmed cell death in situ in the striatum of normal adult rat brain and its relationship to neuronal death during aging. Brain Res 1995; 677:177-79
60. Braak H, Braak E. Neuropathological stageing of Alzheimer-related changes. Acta Neuropathol 1991;82:239-59
61. Dragunow M, Faull RLM, Lawlor P, Beilharz EJ, Singleton K, Walker EB, Mee E. In situ evidence for DNA fragmentation in Huntington's disease and Alzheimer's disease temporal lobes. Neuroreport 1995;6:1053-57
62. Mullaart E, Lohman PHM, Berends F, Vijg J. DNA damage metabolism and aging. Mutat Res 1990;237:189-210
63. MacManus JP, Buchan AM, Hill IE, Rasquinha I, Preston E. Global ischemia can cause DNA fragmentation indicative of apoptosis in rat brain. Neurosci Lett 1993;164:89-92
64. Ravid R, Van Zwieten EJ, Swaab DF. Brain banking and the human hypothalamus - factors to match for, pitfalls and potentials. Progr Brain Res 1992;93:83-95
65. Smale G, Nichols NR, Brady DR, Finch CE, Horton WE, Jr. Evidence for apoptotic cell death in Alzheimer's disease. Exp Neurol 1995;133:225-30
66. Gehrmann J, Banati RB. Microglial turnover in the injured CNS: Activated microglia undergo delayed DNA fragmentation following peripheral nerve injury. J Neuropathol Exp Neurol 1995;54:680-88
67. De Groot CJA, Theeuwes J-WM, Dijkstra CD, Van der Valk P. Postmortem delay effects on neuroglial cells and brain macrophages from Lewis rats with acute experimental allergic encephalomyelitis: An immunohistochemical and cytochemical study. J Neuroimm 1995;59:123-34
68. Goudsmit E, Hofman MA, Fliers E, Swaab DF. The supraoptic and paraventricular nuclei of the human hypothalamus in relation to sex, age and Alzheimer's disease, Neurobiol Aging 1990;11:529-36
69. Van der Woude PF, Goudsmit E, Wierda M, Purba JS, Hofman MA, Bogte H, Swaab DF. Increase in the number of vasopressin immunoreactive cells in the human paraventricular nucleus with normal aging but not in Alzheimer's disease. Neurobiol Aging 1995; 16:11-18
70. Loo DT, Copani A, Pike CJ, Whitemore ER, Walencewicz AJ, Cotman CW. Apoptosis is induced by β-amyloid in cultured central nervous system neurons. Proc Natl Acad Sci USA 1993;90:7951-55
71. Johnson EM. Possible role of neuronal apoptosis in Alzheimer's disease. Neurobiol Aging 1994;15(suppl. 2):S187-S189
72. Su JH, Anderson A, Cummings BJ, Cotman CW. Immunohistochemical evidence for apoptosis in Alzheimer's disease. Neuroreport 1994;5:2529-33
73. Cotman CW, Anderson AJ. A potential role for apoptosis in neurodegeneration and Alzheimer's disease. Mol Neurobiol 1995;10: 19-45
74. Behl C, Davis JB, Klier FG, Schubert D. Amyloid β peptide induces necrosis rather than apoptosis. Brain Res 1994;645:253-64
75. O'Barr S, Schultz J, Rogers J. Expression of the protooncogene bcl-2 in Alzheimer's disease brain. Neurobiol Aging 1996;17:131-36
76. Portera-Cailliau C, Hedreen JC, Price DL, Koliatsos VE. Evidence for apoptotic cell death in Huntington's disease and excitotoxic animal models. J Neurosci 1995;15:3775-87
77. Paradis E, Douillard H, Koutroumanis M, Goodyer C, LeBlanc A. Amyloid β-peptide of Alzheimer's disease downregulates bcl-2 and upregulates Bax expression in human neurons. J Neurosci 1996;16: 7533-39
78. Satou T, Cummings BJ, Cotman CW. Immunoreactivity for bcl-2 protein within neurons in the Alzheimer's disease brain increases with disease severity. Brain Res 1995;697:35-43
79. LeBlanc A. Increased production of 4 kDa amyloid β peptide in serum deprived human primary neuron cultures: Possible involvement of apoptosis. J Neurosci 1995;15:7837-46
80. Kerr JFR, Wyllie AH, Currie AR. Apoptosis: A basic biological phenomenon with wide-ranging implications in tissue kinetics. Br J Cancer 1972;26:239-57
81. Wyllie AH. Cell death: A new classification separating apoptosis from necrosis. In: Bowen ID, Lockshin RA, eds. Cell death in biology and pathology. London, Chapman and Hall, 1991:9-21
82. Rose CD, Henneberry RC. Mechanisms of programmed cell death and their implications for the brain. Neurodegeneration 1993;12: 287-98
83. Regeur L, Badsberg Jensen G, Pakkenberg H, Evans SM, Pakkenberg B. No global neocortical nerve cell loss in brains from patients with senile dementia of Alzheimer's type. Neurobiol Aging 1994; 15:347-52
84. Davison FD, Groves M, Scaravilli F. The effects of formalin fixation on the detection of apoptosis in human brain by in situ end labeling of DNA. Histochem J 1995;27:983-88
85. Thompson C. Apoptosis in the pathogenesis and treatment of disease. Science 1994;267:1456-62
86. Simic G, Kostovic I, Winblad B, Bogdanovic N. Volume and number of neurons of the human hippocampal formation in normal aging and Alzheimer's disease 1997;379:482-94